![Melissa Bradford-Klug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Melissa Bradford-Klug
Directeur Général chez
Mayfield Pharmaceuticals, Inc.
Profil
Melissa Bradford-Klug is currently the Chief Executive Officer at Mayfield Pharmaceuticals, Inc. She also holds the position of Director at Massachusetts Biotechnology Council since 2015.
Previously, she served as the Chief Business Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she was the Senior VP-Business Development & Strategy at AMAG Pharmaceuticals, Inc. from 2014 to 2016.
From 2004 to 2014, she worked at Mallinckrodt Pharmaceuticals Ltd. as the Vice President-Corporate Development & Strategy.
Ms. Bradford-Klug was also the President & Chief Business Officer at Citrine Medicine, Inc. from 2020 to 2022, and the Chief Operating Officer at Akari Therapeutics Plc from 2022 to 2024.
She holds an MBA from DePaul University and an undergraduate degree from Maryville University of St. Louis.
Postes actifs de Melissa Bradford-Klug
| Sociétés | Poste | Début |
|---|---|---|
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Membre du Conseil | 01/03/2015 |
Mayfield Pharmaceuticals, Inc.
 Mayfield Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Anciens postes connus de Melissa Bradford-Klug
| Sociétés | Poste | Fin |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Directeur des opérations | 01/05/2024 |
Citrine Medicine, Inc.
 Citrine Medicine, Inc. BiotechnologyHealth Technology Develops therapies for rare disease patients with unmet medical needs | President | 01/06/2022 |
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | 12/12/2018 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2016 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2014 |
Formation de Melissa Bradford-Klug
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
DePaul University
 DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maryville University of St. Louis
 Maryville University of St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mayfield Pharmaceuticals, Inc.
Mayfield Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Citrine Medicine, Inc.
Citrine Medicine, Inc. BiotechnologyHealth Technology Develops therapies for rare disease patients with unmet medical needs | Health Technology |
